← Back to all trials
Recruiting
NCT07726420
HEARTBEAT-TROP. Polyethylene Glycol Precipitation to Unmask Macrotroponin
Conditions: Diagnoses Disease
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: Yes
Phase: NA
Enrollment: 160
Sponsor: Technical University of Munich
Location: Technical University Munich Munich Bavaria
Summary
Troponin elevation can, among others, be due to myocardial infarction, acute inflammation or structural heart disease. Formation of macrocomplexes against troponin is an underestimated cause for persistent troponin elevation. Polyethlylene glycol precipitation (PEG) can differentiate macrotroponin from real troponin elevation, but cut-off values for PEG have not been established. PEG is analyzed in patients with acute coronary syndrome undergoing invasive coronary angiography and compared to healthy marathon runners who have undergone cardiological pre-participation screening and have rested for 24 hours.
Eligibility Criteria
Inclusion Criteria:
* Age above 18 years
* Group with acute coronary syndrome (ACS): Diagnosis of ACS (ST-segment elevation or non-ST-segment elevation myocardial infarction according to the European Society of Cardiology Guidelines 2023 with at least one measurement of high sensitive troponin I or T above the 99th percentile of reference).
* Marathon runners: Participation in a marathon following cardiological pre-participation screening and medical clearance for competition. No clinical signs of cardiovascular or structural heart disease
Exclusion Criteria:
* Patients with acute coronary syndrome: Known macrotroponin, terminal renal disease (glomerular filtration rate below 10ml per minute), diagnosis of cancer, pregnancy
* Marathon runners: Coronary artery disease, structural heart disease, diagnosis of cancer, pregnancy
Source: ClinicalTrials.gov (NCT07726420). StuddyBuddy aggregates publicly available trial information.